Breast cancer trends in 2021 and beyond

• Date : 2020-12-12
• 5    
  0

ALTERNATE: neoadjuvant chemotherapy in ER+ HER2- breast cancer

• Date : 2020-12-12
• 2    
  0

Tailoring medicine in breast cancer

• Date : 2020-12-11
• 0    
  0

Strategies to improve wellbeing in breast cancer patients

• Date : 2020-12-11
• 0    
  0

Future of breast cancer care: HER2 therapies in earlier settings & de-escalation

• Date : 2020-12-11
• 0    
  0

monarchE: abemaciclib and adjuvant endocrine therapy for high-risk HR+ early breast cancer

• Date : 2020-12-11
• 0    
  0

RxPONDER: sparing chemotherapy in node-positive early-stage breast cancer

• Date : 2020-12-11
• 0    
  0

Treatment optimization trials in breast cancer

• Date : 2020-12-11
• 0    
  0

Circulating tumor cells as a treatment monitoring tool in metastatic breast cancer

• Date : 2020-12-11
• 0    
  0

Neratinib, trastuzumab + fulvestrant for HER2-mutant, HR+, metastatic breast cancer

• Date : 2020-12-11
• 0    
  0

ASCENT: sacituzumab govitecan biomarker analysis

• Date : 2020-12-11
• 0    
  0

RIBECCA: ribociclib, a CDK4/6 inhibitor in ER+ breast cancer

• Date : 2020-12-11
• 0    
  0

AMEERA-3: SERD for ER+ HER2- breast cancer

• Date : 2020-12-11
• 0    
  0

Future advances in DCIS: de-escalation of hormonal therapy

• Date : 2020-12-11
• 0    
  0

CONTESSA: tesataxel in HR+ breast cancer

• Date : 2020-12-11
• 0    
  0

SABCS 2020: endocrine combination therapy & adjuvant chemotherapy in node-positive patients

• Date : 2020-12-11
• 0    
  0

MARIO-3: eganelisib in TNBC

• Date : 2020-12-11
• 0    
  0

Novel targeted therapies in breast cancer

• Date : 2020-12-11
• 0    
  0

Immune oncology in breast cancer: KEYNOTE-086, NCI 10013, & AIPAC

• Date : 2020-12-11
• 0    
  0

E2112: endocrine therapy plus entinostat in HR+ advanced breast cancer

• Date : 2020-12-11
• 0    
  0

IMpassion031: patient-reported outcomes

• Date : 2020-12-11
• 0    
  0

HER2CLIMB: outcomes by hormone receptor status

• Date : 2020-12-11
• 0    
  0

Next steps in breast cancer: de-escalation & immunotherapy

• Date : 2020-12-11
• 0    
  0

Next questions in breast cancer treatment

• Date : 2020-12-11
• 0    
  0

ESMO Clinical Practice Guidelines: fertility preservation & management of post-treatment pregnancies

• Date : 2020-12-11
• 0    
  0

Reducing disparities in breast cancer care

• Date : 2020-12-11
• 0    
  0

Challenges in applying AI in healthcare

• Date : 2020-12-11
• 0    
  0

SABCS 2020: contextualising the impact of the COVID-19 pandemic on breast cancer care

• Date : 2020-12-11
• 0    
  0

Upcoming advances in precision medicine at SABCS 2020

• Date : 2020-12-11
• 0    
  0

Future of genomics in breast cancer care

• Date : 2020-12-11
• 0    
  0

The importance of patient reported outcomes in breast cancer

• Date : 2020-12-11
• 0    
  0

HER2CLIMB-02: tucatinib + TDM-1 in advanced breast cancer

• Date : 2020-12-11
• 0    
  0

Physician adoption of NGS in the care of breast cancer patients

• Date : 2020-12-11
• 0    
  0

Phase III study of plinabulin and pegfilgrastim for chemotherapy-induced neutropenia

• Date : 2020-12-11
• 0    
  0

The role of gut microbiome in breast cancer risk

• Date : 2020-12-11
• 0    
  0

Biology informing treatment decisions in breast cancer

• Date : 2020-12-11
• 0    
  0

Innovative biomarker approaches in breast cancer therapy

• Date : 2020-12-11
• 0    
  0

Using AI improve mammograms in breast cancer screening

• Date : 2020-12-11
• 0    
  0

SABCS 2020: monarchE, PENELOPE-B, TAILORx & ASCENT

• Date : 2020-12-11
• 0    
  0

Using biology to identify best outcomes

• Date : 2020-12-11
• 0    
  0

Chances of pregnancy after breast cancer

• Date : 2020-12-11
• 0    
  0

ASCENT: sacituzumab govitecan shows promise in mTNBC patients

• Date : 2020-12-11
• 0    
  0

Improving risk prediction and decision making in DCIS patients

• Date : 2020-12-11
• 0    
  0

SWOG S9313: classification of TNBC by DNA damage response + homologous recombination deficiency

• Date : 2020-12-11
• 0    
  0

12-year results of anastrozole vs tamoxifen for breast cancer prevention

• Date : 2020-12-11
• 0    
  0

PENELOPE-B: palbociclib with endocrine therapy in HR+, HER2-negative breast cancer

• Date : 2020-12-11
• 0    
  0

An evaluation of the impact of DCIS diagnosis on the patients' wellbeing

• Date : 2020-12-11
• 0    
  0

Congrès ESMO 2026

• Date : 2026-10-23
• 50    
  0

Congrès ESMO d'Immuno-Oncologie 2025

• Date : 2025-12-10
• 132    
  0

SABCS 2025 Symposium

• Date : 2025-12-09
• 5325    
  0

Congrès ESMO Asie 2025

• Date : 2025-12-05
• 303    
  0

17ᵉ Congrès Européen Multidisciplinaire sur le Cancer Urologique - EMUC25

• Date : 2025-11-13
• 461    
  0